Epidemiological survey of drug resistance of methicillin-resistant Staphylococcus aureus isolated in Japan in 2000

Japanese Journal of Chemotherapy

Volumn 50, Issue 8, 2002, Pages 494-499

  Kurazono, Mizuyo ^a   Yamada, Keiko ^a   Hirai, Yoko ^a   Ida, Takashi ^a   Inoue, Matsuhisa ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arbekacin; MRS; Vancomycin

Indexed keywords

BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; COAGULASE; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FLOMOXEF; GATIFLOXACIN; GENTAMICIN; HABEKACIN; IMIPENEM; LINEZOLID; LIVIDOMYCIN; METICILLIN; MINOCYCLINE; OFLOXACIN; PSEUDOMONIC ACID; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG POTENCY; EPIDEMIOLOGY; GRAM POSITIVE BACTERIUM; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PUS; SEROTYPE; SPUTUM CULTURE;

EID: 0036696652     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Japanese source. Jap J Antibiotics 47: 585-594, 1994
2. Inoue M, Nonoyama M, Okamoto R, et al.: Antimicrobial activity of arbekacin, a new aminoglycoside antibiotics, against methicillin-resistant Staphylococcus aureus. Drug Exptl Clin Res 20: 233-240, 1994
3. Japanese source. p.113-135, 1992
4. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Laboratory Standards, Wayne, Pa, 2000
5. Ida T, Okamoto R, Shimauchi C, et al.: Identification of aminoglycoside-modifying enzymes by susceptibility testing: Epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J Clin Microbiol 39: 3115-3121, 2001
6. Hiramatsu K: Molecular evolution of MRSA. Microbiol Immunol 39: 531-543, 1995
7. Tanaka T, Okusumi K, Iwamoto A, et al.: A retrospective study on methicillin - resistant Staphylococcus aureus clinical strains in Tokyo University Hospital. J Infect Chemother 1: 42-51, 1995
8. Japanese source. Jap J Antibiotics 47: 627-633, 1994
9. Japanese source. MRSA 55: 373, 2000
10. Ike Y, Arakawa Y, Ma X, et al.: Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospital. J Clin Microbiol 39: 4445-4451, 2001
11. Hiramatsu K, Aritake K, Hanaki H, et al.: Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350: 1670-1673, 1997.
12. Japanese source. 47 (S-2): 48-56, 1999
13. Fukuda H, Hori S, Hiramatsu K: Antibacterial activity of gatifloxacin (AM-1155), CG 5501, BMS -206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and norA transformat of Staphylococcus aureus. Antimicrob Agents Chemother 42: 1917-1922, 1998
14. Betriu C, Redondo M, Boloix A: Comparative activity of linezolid and other agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. J Antimicrob Chemother 48: 911-913, 2001
15. Japanese source. Jap J Antibiotics 52:302-312, 1999
16. Inoue M, Okamoto R, Okubo T, et al.: Comparative in-vitro activity of RP 59500 against clinical bacterial isolates. J Antimicrob Chemother 30 (S-A): 45-51, 1992
17. Aumercier M, Bouhallabs S, Capmau M L, et al.: RP 59500: a proposed mechanism for its bactericidal activity. J Antimicrob Chemother 30 (S-A): 9-14, 1992